BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10475393)

  • 1. Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers.
    Lee YC; Chang YL; Luh SP; Lee JM; Chen JS
    Ann Thorac Surg; 1999 Aug; 68(2):343-7; discussion 348. PubMed ID: 10475393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
    Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
    J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers.
    Tammemagi MC; McLaughlin JR; Bull SB
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):625-34. PubMed ID: 10428201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and disease progression in patients with non-small cell lung cancer.
    Sauter ER; Gwin JL; Mandel J; Keller SM
    Surg Oncol; 1995 Jun; 4(3):157-61. PubMed ID: 7582188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer.
    Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH
    Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.
    Xu HJ; Hu SX; Cagle PT; Moore GE; Benedict WF
    Cancer Res; 1991 May; 51(10):2735-9. PubMed ID: 1850661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
    Saitoh G; Sugio K; Ishida T; Sugimachi K
    Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer.
    Lee YC; Wu CT; Kuo SW; Tseng YT; Chang YL
    Chest; 2007 Apr; 131(4):993-9. PubMed ID: 17426201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 and RB proteins in squamous cell carcinoma of the esophagus: their relationship with clinicopathologic characteristics.
    Hashimoto N; Tachibana M; Dhar DK; Yoshimura H; Nagasue N
    Ann Surg Oncol; 1999; 6(5):489-94. PubMed ID: 10458688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
    Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
    Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of multiple gene mutations in non-small-cell lung cancer by suspension microarray].
    Wang D; Ye YK; Su CQ; Rong TH; Guo AY; Yi JH; Liu YJ
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3393-6. PubMed ID: 20223111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.